Published in Exp Parasitol on April 03, 2013
Species typing in dermal leishmaniasis. Clin Microbiol Rev (2015) 0.97
Detection and characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR green-based real-time PCR and high resolution melt analysis targeting kinetoplast minicircle DNA. PLoS One (2014) 0.93
Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol (2015) 0.93
Comparison between conventional and real-time PCR assays for diagnosis of visceral leishmaniasis. Biomed Res Int (2014) 0.83
Field validation of SYBR® Green- and TaqMan®-based real-time PCR using biopsy and swab samples to diagnose American tegumentary leishmaniasis in a Leishmania (V.) braziliensis-endemic area. J Clin Microbiol (2016) 0.80
Current status of L. infantum infection in stray cats in the Madrid region (Spain): implications for the recent outbreak of human leishmaniosis? Parasit Vectors (2014) 0.79
Leishmaniases diagnosis: an update on the use of immunological and molecular tools. Cell Biosci (2015) 0.79
An overview on Leishmania vaccines: A narrative review article. Vet Res Forum (2015) 0.77
Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis. Parasit Vectors (2016) 0.75
NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis. Biomed Res Int (2016) 0.75
Identification of Leishmania infantum in Puerto Iguazú, Misiones, Argentina. Rev Inst Med Trop Sao Paulo (2015) 0.75
Detection and Differentiation of Leishmania spp. in Clinical Specimens Using a SYBR Green-Based Real-Time PCR Assay. J Clin Microbiol (2016) 0.75
Evaluation of four molecular methods to detect Leishmania infection in dogs. Parasit Vectors (2017) 0.75
Expanding the knowledge about Leishmania species in wild mammals and dogs in the Brazilian savannah. Parasit Vectors (2015) 0.75
Molecular detection of Leishmania infantum and Leishmania tropica in rodent species from endemic cutaneous leishmaniasis areas in Morocco. Parasit Vectors (2017) 0.75
The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev (2008) 5.32
Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure. Circ Res (2007) 3.51
Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation (2006) 2.47
Canine leishmaniasis. Adv Parasitol (2004) 2.44
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis (2007) 2.33
Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis (2008) 2.24
Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation (2003) 1.86
Leishmania/HIV co-infections in the second decade. Indian J Med Res (2006) 1.73
Rice NTRC is a high-efficiency redox system for chloroplast protection against oxidative damage. Plant Cell (2006) 1.63
Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol (2005) 1.58
Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One (2010) 1.54
Periodic iron nanomineralization in human serum transferrin fibrils. Angew Chem Int Ed Engl (2008) 1.52
Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol (2008) 1.50
Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infect Genet Evol (2008) 1.49
Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon, Spain. Am J Trop Med Hyg (2004) 1.48
Errors in pulmonary vein identification and ostia location in the absence of pulmonary vein imaging. Heart Rhythm (2005) 1.46
Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. Am J Trop Med Hyg (2007) 1.44
Cutaneous leishmaniasis in Nepal: Leishmania major as a cause. Trans R Soc Trop Med Hyg (2008) 1.41
KATP channel opening accelerates and stabilizes rotors in a swine heart model of ventricular fibrillation. Cardiovasc Res (2013) 1.41
Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunologic tools. Am J Trop Med Hyg (2007) 1.39
[Differentiating between atrial flutter and atrial fibrillation using right atrial bipolar endocardial signals]. Rev Esp Cardiol (2007) 1.39
In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Antimicrob Agents Chemother (2008) 1.33
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. PLoS Negl Trop Dis (2012) 1.27
Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol (2006) 1.26
Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia. Am J Trop Med Hyg (2009) 1.25
Differentiation and gene flow among European populations of Leishmania infantum MON-1. PLoS Negl Trop Dis (2008) 1.23
Three distinct phases of VF during global ischemia in the isolated blood-perfused pig heart. Am J Physiol Heart Circ Physiol (2007) 1.22
Diagnosis of visceral leishmaniasis: developments over the last decade. Parasitol Res (2011) 1.21
Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin Immunol (2006) 1.19
Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis. Trends Parasitol (2010) 1.19
American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility? J Infect Dis (2006) 1.17
Short communication: post-kala-azar dermal leishmaniasis--an appraisal. Trop Med Int Health (2007) 1.15
Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis (2008) 1.15
A simplified and standardized polymerase chain reaction format for the diagnosis of leishmaniasis. J Infect Dis (2008) 1.14
Universal scaling law of electrical turbulence in the mammalian heart. Proc Natl Acad Sci U S A (2007) 1.13
Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. J Infect Dis (2006) 1.13
Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am J Trop Med Hyg (2003) 1.13
A purL mutant of Sinorhizobium fredii HH103 is symbiotically defective and altered in its lipopolysaccharide. Microbiology (2003) 1.13
Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One (2010) 1.12
Comparison of molecular markers for strain typing of Leishmania infantum. Infect Genet Evol (2006) 1.09
Drug regimens for visceral leishmaniasis in Mediterranean countries. Trop Med Int Health (2008) 1.07
[Comparison of conventional and non-conventional serological tests for the diagnosis of imported Chagas disease in Spain]. Enferm Infecc Microbiol Clin (2009) 1.07
Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol (2007) 1.07
Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania. J Biol Chem (2004) 1.06
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother (2004) 1.06
Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Negl Trop Dis (2011) 1.05
Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis (2006) 1.05
A canine leishmaniasis pilot survey in an emerging focus of visceral leishmaniasis: Posadas (Misiones, Argentina). BMC Infect Dis (2010) 1.03
Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin. Antivir Ther (2004) 1.02
Sinorhizobium fredii HH103 mutants affected in capsular polysaccharide (KPS) are impaired for nodulation with soybean and Cajanus cajan. Mol Plant Microbe Interact (2006) 1.02
Hypopigmented post-kala-azar dermal leishmaniasis. Int J Dermatol (2008) 1.02
Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation. J Cardiovasc Electrophysiol (2010) 1.02
Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1. J Infect Dis (2002) 1.01
Six-month follow-up multicenter prospective study of 368 patients, phototypes III to V, on epilation efficacy using an 810-nm diode laser at low fluence. Lasers Med Sci (2010) 1.01
In vivo-applied functional RNAs as tools in proteomics and genomics research. Trends Biotechnol (2002) 1.00
Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani. Parasitol Res (2012) 1.00
Multilocus polymerase chain reaction restriction fragment--length polymorphism genotyping of Trypanosoma cruzi (Chagas disease): taxonomic and clinical applications. J Infect Dis (2007) 1.00
Accurate and rapid species typing from cutaneous and mucocutaneous leishmaniasis lesions of the New World. Diagn Microbiol Infect Dis (2012) 1.00
SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. J Neurovirol (2006) 1.00
Cytokine profiles in canine visceral leishmaniasis. Vet Immunol Immunopathol (2008) 0.99
Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol. PLoS Negl Trop Dis (2012) 0.98
Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet Dermatol (2009) 0.98
Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquine. Antimicrob Agents Chemother (2011) 0.97
A patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India. Am J Trop Med Hyg (2011) 0.97
Fluorogenic assay for molecular typing of the Leishmania donovani complex: taxonomic and clinical applications. J Infect Dis (2005) 0.97
Mitochondrial associated ubiquitin fold modifier-1 mediated protein conjugation in Leishmania donovani. PLoS One (2011) 0.96
Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence. Mol Microbiol (2010) 0.96
Selection of endogenous reference genes for gene expression analysis in Leishmania major developmental stages. Parasitol Res (2007) 0.96
Isolation and molecular identification of Leishmania (Viannia) peruviana from naturally infected Lutzomyia peruensis (Diptera: Psychodidae) in the Peruvian Andes. Mem Inst Oswaldo Cruz (2007) 0.95
Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. Int J Antimicrob Agents (2010) 0.95
Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal Leishmaniasis Lesions. J Clin Microbiol (2004) 0.94
Factors associated with Leishmania asymptomatic infection: results from a cross-sectional survey in highland northern Ethiopia. PLoS Negl Trop Dis (2012) 0.94
Leishmania OligoC-TesT as a simple, rapid, and standardized tool for molecular diagnosis of cutaneous leishmaniasis in Peru. J Clin Microbiol (2009) 0.94
Evolution of the Leishmania braziliensis species complex from amplified fragment length polymorphisms, and clinical implications. Infect Genet Evol (2012) 0.94
Reliable diagnosis of post-kala-azar dermal leishmaniasis (PKDL) using slit aspirate specimen to avoid invasive sampling procedures. Trop Med Int Health (2012) 0.94
Deletion of mitochondrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of β-oxidation of fatty acids and blocks cell division in the amastigote stage. Mol Microbiol (2012) 0.93
Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice. J Immunol (2013) 0.92
Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet Immunol Immunopathol (2005) 0.92
Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters. J Clin Microbiol (2013) 0.92
In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis. Am J Trop Med Hyg (2013) 0.92
A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol (2010) 0.91
Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors. Immunology (2010) 0.91
Low prevalence of Leishmania infection in post-epidemic areas of Libo Kemkem, Ethiopia. Am J Trop Med Hyg (2012) 0.91
Genetically modified live attenuated parasites as vaccines for leishmaniasis. Indian J Med Res (2006) 0.91
Investigating the mechanism of the nucleocapsid protein chaperoning of the second strand transfer during HIV-1 DNA synthesis. J Mol Biol (2007) 0.91
Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol (2009) 0.91
Fatal congenital Chagas' disease in a non-endemic area: a case report. Cases J (2008) 0.91
Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites. J Trop Med (2011) 0.91
Routine chest roentgenogram after central venous catheter insertion is not always necessary. Am J Surg (2003) 0.90
Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia. Am J Trop Med Hyg (2012) 0.90
Cellular and humoral responses to Leishmania major virulence factors in healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients. Clin Vaccine Immunol (2009) 0.90
Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers. World J Gastroenterol (2006) 0.90